The Microbiome in Cancer Development and Therapy

Microbiota can influence carcinogenesis via chronic inflammation, DNA damage, or altering immune responses. Certain bacteria like Fusobacterium nucleatum have been linked to colorectal cancer, while others enhance the efficacy of immunotherapy. This session explores the microbiome’s dual role in cancer—as a risk factor and therapeutic enhancer—and presents research on microbiome biomarkers, microbial drug metabolism, and potential interventions for cancer prevention and treatment optimization.

 

    Related Conference of The Microbiome in Cancer Development and Therapy

    September 22-23, 2025

    13th World Congress and Expo on Applied Microbiology

    Dubai, UAE
    November 03-04, 2025

    54th World Congress on Microbiology

    Rome, Italy

    The Microbiome in Cancer Development and Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in